|
Volumn 38, Issue 6, 2006, Pages 1933-1936
|
No Induction Versus Anti-IL2R Induction Therapy in Simultaneous Kidney Pancreas Transplantation: A Comparative Analysis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BASILIXIMAB;
DACLIZUMAB;
INTERLEUKIN 2 RECEPTOR;
METHYLPREDNISOLONE;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
OKT 3;
PREDNISONE;
TACROLIMUS;
ACUTE GRAFT REJECTION;
ADULT;
ARTICLE;
CLINICAL PROTOCOL;
COMPARATIVE STUDY;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG SAFETY;
GRAFT SURVIVAL;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY GRAFT REJECTION;
KIDNEY PANCREAS TRANSPLANTATION;
MAINTENANCE THERAPY;
MAJOR CLINICAL STUDY;
PRIORITY JOURNAL;
SEPSIS;
SURVIVAL;
ADULT;
ANTIBODIES, MONOCLONAL;
BIOPSY;
CYTOMEGALOVIRUS INFECTIONS;
DRUG THERAPY, COMBINATION;
GRAFT REJECTION;
GRAFT SURVIVAL;
HUMANS;
IMMUNOGLOBULIN G;
IMMUNOSUPPRESSION;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
MYCOPHENOLIC ACID;
PANCREAS TRANSPLANTATION;
PATIENT SELECTION;
PREDNISONE;
RECEPTORS, INTERLEUKIN-2;
SURVIVAL ANALYSIS;
|
EID: 33746870730
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2006.06.072 Document Type: Article |
Times cited : (10)
|
References (7)
|